Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T23761
|
||||
Former ID |
TTDS00517
|
||||
Target Name |
Sarcoplasmic/endoplasmic reticulum calcium ATPase
|
||||
Synonyms |
ATP4; Ca(2+)-ATPase; Ca2+-ATPase; Calcium pump; Calcium-transporting ATPase; SERCA; SERCA pump; SR Ca(2+)-ATPase
|
||||
Target Type |
Successful
|
||||
Disease | Malaria [ICD10: B54] | ||||
BioChemical Class |
Acid anhydrides hydrolase
|
||||
Target Validation |
T23761
|
||||
EC Number |
EC 3.6.3.8
|
||||
Drugs and Mode of Action | |||||
Drug(s) | Artemisinin | Drug Info | Approved | Malaria | [536602] |
Artemisinin SP | Drug Info | Approved | Malaria | [536602] | |
Artesunate | Drug Info | Approved | Malaria | [536602] | |
Dihydroartemisinin | Drug Info | Approved | Malaria | [536602] | |
OZ277 | Drug Info | Approved | Malaria | [536602] | |
Piperaquine | Drug Info | Approved | Malaria | [536602] | |
Pyronaridine | Drug Info | Approved | Malaria | [551871] | |
Artesunate | Drug Info | Phase 2 | Malaria | [551871] | |
THAPSIGARGIN | Drug Info | Preclinical | Discovery agent | [540789], [545050] | |
Inhibitor | Artemisinin | Drug Info | [536602] | ||
Artemisinin SP | Drug Info | [536602] | |||
Artesunate | Drug Info | [536602] | |||
Cyclopiazonic acid | Drug Info | [535098] | |||
Dihydroartemisinin | Drug Info | [536602] | |||
OZ277 | Drug Info | [536602] | |||
Piperaquine | Drug Info | [536602] | |||
Pyronaridine | Drug Info | [536602] | |||
THAPSIGARGIN | Drug Info | [531021] | |||
Vanadate | Drug Info | [535098] | |||
References | |||||
Ref 536602 | The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs. Curr Med Chem. 2008;15(2):161-71. | ||||
Ref 540789 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5351). | ||||
Ref 531021 | Bioorg Med Chem. 2010 Aug 1;18(15):5634-46. Epub 2010 Jun 16.Elucidation of the topography of the thapsigargin binding site in the sarco-endoplasmic calcium ATPase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.